Gherman A, Căinap C, Constantin A-M, Cetean S, Căinap S. Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab. Medicine and Pharmacy Reports [Internet]. 30Oct.2017 [cited 21Nov.2024];90(4):377-84. Available from: https://medpharmareports.com/index.php/mpr/article/view/745